As such, Aβ-related increases in soluble p-tau may be a key initial step in the Aβ cascade that determines the accumulation of aggregated tau pathology, and thereby leading to faster cognitive decline in early AD, and this cascade of events was even found in the preclinical stage of the disease. Here, MAPT is linked to Alzheimer disease.